Hesitancy around Covid vaccination

A poll carried out by the Royal Society for Public Health in December found that just 57% of respondents from black or ethnic minority backgrounds were likely to accept a Covid-19 vaccine, compared to 79% of white respondents. The poll also found that BAME respondents who were not willing to be vaccinated were especially receptive to offers of further health information from their GP. Over one third (35%) said they would likely change their minds and get the jab if given more information by their GP about how effective it is.

Londonwide LMCs welcomes work to improve vaccine uptake and address vaccine hesitancy in London, particularly amongst BAME communities. The Mayor of London, Greater London Authority and NHS England London are planning pan-London Q&As with specific vaccine hesitant communities over the next few months and we will share information on these events as we receive it.

There is a Covid-19 vaccine seminar organised by the NHS Race and Health Observatory on Thursday 11 February from 5-7pm. You can join the webinar live via Microsoft Teams (this link will become active close to the start of the event).

 

You and your team may also find the following FAQs of assistance when addressing concerns raised by patients:

 

Has the vaccine been ‘rushed through’, is it safe?

The vaccines developed by Pfizer/BioNTech and Oxford-AstraZeneca have been approved for use in the UK and have met strict current standards of safety, quality and effectiveness set out by the independent Medicines and Healthcare products Regulatory Agency (MHRA).

Any coronavirus vaccine that is approved must go through all the clinical trials and safety checks all other licensed medicines go through and the UK has some of the highest safety standards in the world. So far, thousands of people have been given a Covid-19 vaccine in the clinical trials and no serious side effects or complications have been reported. However there is a very small risk of an allergic reaction which was identified when the programme was expanded to the general population (see further information below).

In clinical trials most of the time is spent waiting whilst funding is applied for and the trial is approved - the waiting and logistics take time. Covid-19 has a world-wide interest and has shown if you bring together very clever people, unlimited money and high numbers of volunteers you can create a vaccine in under a year. Safety has not been compromised as the regulatory bodies have had access along the way.

 

If it isn’t safe for children and pregnant women, how is it safe for me?

All medicines, including vaccines, rely on clinical trials to determine their safety. Trials are not carried out routinely in pregnancy, therefore there is no data as of yet on the safety of Covid-19 vaccines in pregnancy, either from human or animal studies.

Given the lack of evidence and as a precautionary approach pregnant women should not receive the vaccine, unless they are at a very high risk of becoming infected, or of developing severe complications if infected. In which case she should discuss vaccination with a doctor or nurse. Data is anticipated in the future which will inform discussions on vaccination in pregnancy.

Lessons have been learnt from historical mistakes in medicine development and checks and balances have been introduced to mitigate errors of the past. Medical and technological advances allow scientists to collect data in real time. Cascade systems are already in operation so that responses to adverse events are dealt with promptly. Patients are being followed up over the long-term and the safety process will continue, with any reports generated being acted upon as soon as required to protect patients. This system was not available many years ago.

 

Are the vaccine ingredients permissible in my religion?

 

Are there any materials of human or animal origin in the vaccine?

No. There is no material of foetal or animal origin in either vaccine. A detailed review of the vaccines and their ingredients are published on the MHRA’s website.

 

Are there microchips in the vaccine?

No, the vaccines do not contain microchips.

 

How do I know I am not allergic to the vaccine?

Around 40,000 people have been involved in the initial trials, and around 6 million people have been vaccinated in the UK to date, including the Queen and Sir David Attenborough. It is very rare for anyone to have a serious reaction to the vaccine (anaphylaxis). If this does happen, it usually happens within minutes of receiving the vaccine. Staff giving the vaccine are trained to deal with allergic reactions and treat them immediately.

 

What about the side effects?

Minor side effects such as fever, sore arm, headache, are common with the mRNA vaccines, and are seen within a short period of administration. You can report suspected side effects to medicines, vaccines or medical device and diagnostic adverse incidents used in coronavirus treatment to the Medicines and Healthcare products Regulatory Agency using the Yellow Card safety scheme. Visit Yellow Card for further information. At your vaccine appointment you can ask any questions that you might have.

 

Can I wait and have the vaccine later or choose the vaccine I want to have?

Vaccinations are being delivered based on JCVI priority groups. As such, we would not recommend that you wait after being offered a vaccine because the offer indicates that you are in a high-risk group. The delay could be dangerous for you or those you look after.

 

Could the vaccine affect my genes?

There is no evidence to suggest that individual genetic material will undergo an alteration after receiving the vaccine. None of the vaccines approved interfere in any way with your own DNA. Your genes reside in your DNA and the vaccine does not enter your cell nucleus where your DNA resides. You can read more about how mRNA vaccines work here.

 

Do I have to have the vaccine?

No, you have the right to refuse. Vaccines are not mandatory in the UK. However we would encourage you to read information from creditable sources to make an informed decision.

 

Will the vaccine give me Covid-19?

No, you cannot catch Covid-19 from the vaccine. It is not a live vaccine therefore you would not be injected with the actual virus. If you test positive after vaccination it is possible you may have caught Covid-19 before being vaccinated and not realise until after you had the vaccine. If you have symptoms of Covid-19 around the time of vaccination, then you should self-isolate and get a test. You may have some minor side effects, but this is normal. The vaccine typically takes until three weeks after the first dose is administered to provide protection from the virus.

 

I have already had Covid-19 – I don’t need to be vaccinated, do I?

Past Covid-19 infection provides some immunity, but people may still carry and transmit the virus to other people. It is advisable to have the vaccine even if you have already been infected with Covid-19. 

 

Can I transmit the virus to other people after I’ve been vaccinated?

We don’t know yet therefore you need to still follow the guidance to help keep other people safe. The vaccines are highly effective at preventing the person vaccinated from becoming ill or dying from Covid-19. Research is underway to answer this question, so it is is essential that people continue to follow the government guidelines (hands, face, space) after they’ve been vaccinated. 

 

Is translated information about the vaccination programme available?

 

Other sites with useful Q&A sections on them include:

Last updated : 28 Jan 2021

 

‘Innovative and interesting’ HCA course now incorporates the 15 Care Certificate Standards (21 Nov 2017)

“I would recommend it to other HCAs, a very good course”. “The trainers were excellent”. “Facilitators have a good knowledge of their subjects and they explained clearly”. These are just...
Read more »

London Health and Care Devolution Memorandum of Understanding signed (21 Nov 2017)

The London Health and Care Devolution Memorandum of Understanding (MoU) was signed last week by London, national partners and central government. We currently have some high-level details which we can...
Read more »

BMA referral to a specialist patient leaflet (17 Nov 2017)

The BMA has launched a new leaflet which is designed to provide patients with information on what to expect when referred to a specialist. The leaflet can be downloaded...
Read more »

Practice managers please respond to records update email (17 Nov 2017)

In the next few weeks, we will be sending an email to all practice managers asking them to confirm the GPs who are working at their practice, please look out...
Read more »

Request for hospitals to issue fit notes gets results (17 Nov 2017)

Our recent letters to hospital trusts asking them to issue fit notes to patients rather than referring them back to GPs has had a positive response from Imperial College Healthcare...
Read more »

Londonwide LMCs motions at England LMC Representative Conference (17 Nov 2017)

The first Conference of England LMCs took place on 10 November in London. The full list of motions, including which parts were carried can be downloaded here. A summary...
Read more »

Chairs and vice chairs look at cross-LMC working (25 Oct 2017)

Last week’s meeting of Londonwide LMCs’ leaders looked at cross-LMC working, to make sure we are ready to represent members as the NHS brings in new organisations as part of...
Read more »

Participant practices wanted for unique stress and workload study (25 Oct 2017)

Update February 2018: The Primary Care Barometer is now up and running! As of December 2017 practice managers across London have had the exciting opportunity to participate in a novel survey...
Read more »

GPC guidance on requirements for PREVENT training (23 Oct 2017)

Section 26 of the Counter-Terrorism and Security Act 2015 (the Act) places a duty on certain bodies (“specified authorities” listed in Schedule 6 to the Act), in the exercise of...
Read more »

Extended hours DES update (23 Oct 2017)

The 2017/18 changes to the GP contract included the condition that meant practices who regularly close for a half day, on a weekly basis, will not ordinarily qualify to deliver...
Read more »
Next Page »
« Previous Page